Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital
- PMID: 28540038
- PMCID: PMC5431400
- DOI: 10.1177/2045125317693513
Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital
Abstract
Background: High-security hospital patients are often complex in presentation and are characterized by treatment resistance, medication nonadherence and history of violence. Paliperidone is licensed both as an oral and depot antipsychotic medication in the treatment of schizophrenia. Clinical trials have shown that paliperidone depot is well tolerated with similar efficacy to risperidone depot but with additional practical advantages. Whilst data exist for the effectiveness of paliperidone palmitate (PP), there are no studies involving patients in forensic settings or those with comorbid personality disorder. Our aim was to evaluate the effectiveness of PP on violence, aggression and personality disorder symptoms.
Methods: This project was a retrospective service evaluation involving 11 patients, carried out in a high-security hospital. A combination of patient records and interviews with the treating consultant psychiatrist were used to ascertain a Clinical Global Impression (CGI) score, the effect of PP on specific personality disorder symptom domains (cognitive-perceptual, impulsive-behavioural dyscontrol and affective dysregulation) and incidents of violence and aggression. Engagement with occupational and psychological therapies was also evaluated. Metabolic parameters were reviewed.
Results: A total of 6 out of 11 patients continued on PP, most of whom had schizophrenia and dissocial personality disorder with histories of violence. All showed improvement in the CGI score with associated benefits in the three personality symptom domains. Overall, two patients demonstrated a reduction in the risk of violence. There was improvement in engagement with occupational therapy and psychological work. No significant effects on metabolic parameters were noted although hyperprolactinaemia, albeit asymptomatic, was consistently recorded.
Conclusions: This pragmatic service evaluation of a small but complex patient group demonstrated, for the first time, that PP was effective in reducing violence as well as improving personality pathology across all dimensions: a finding which could have significant implications for management of such high-security patients.
Keywords: antipsychotic agents; depot antipsychotic; high-security; paliperidone; personality disorder; schizophrenia; violence.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital.CNS Spectr. 2014 Oct;19(5):391-402. doi: 10.1017/S1092852914000157. Epub 2014 Apr 3. CNS Spectr. 2014. PMID: 24698103 Free PMC article.
-
An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in a UK high-security hospital.Ther Adv Psychopharmacol. 2014 Oct;4(5):186-92. doi: 10.1177/2045125314531982. Ther Adv Psychopharmacol. 2014. PMID: 25360243 Free PMC article.
-
Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.CNS Spectr. 2016 Feb;21(1):60-9. doi: 10.1017/S1092852915000784. Epub 2016 Jan 4. CNS Spectr. 2016. PMID: 26726766
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review.Neuropsychiatr Dis Treat. 2018 Jan 5;14:205-223. doi: 10.2147/NDT.S139633. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29379293 Free PMC article. Review.
References
-
- Adams D. (1979) Brain mechanisms for offence, defence, and submission. Behav Brain Sci 2: 201–213.
-
- Berman M., Tracy J., Coccaro E. (1997) The serotonin hypothesis of aggression revisited. Clin Psychol Rev 17: 651–665. - PubMed
-
- Binks C., Fenton M., McCarthy L., Lee T., Adams C., Duggan C. (2006) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev CD005653. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous